Physician

Asim Farid, M.D.

According to 2025 Medicare claims, Asim Farid, M.D. (NPI: 1194785584) practices colorectal surgery (formerly proctology) in the Rochester, NY market, with the plurality of this provider's patient population coming from Monroe, NY. This provider's primary affiliated billing organization is ROCHESTER COLON AND RECTAL SURGEONS, PC (NPI: 1396702411; TIN: 161153679) and primary practice location at 14623-4300.

Farid's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 92 traditional Medicare patients, billed 210 HCPCS/CPT codes, and received $29,154 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 81 prescription claims across 47 beneficiaries totaling $8,809 in drug costs, led by Mesalamine (Mesalamine). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $48,302 to $29,154. Similarly, Part D prescription costs have declined steadily, from $14,734 to $8,809. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$28K$56K2015 Medicare payment: $48,302 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $50,212 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $42,951 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $56,483 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $49,333 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $33,907 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $45,875 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $29,823 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $36,813 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $29,154 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015170663$48,302
2016154682$50,212
2017134693$42,951
2018148786$56,483
20191421,122$49,333
2020851,019$33,907
2021117694$45,875
202288599$29,823
2023100652$36,813
202492210$29,154

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$11K$22K2015 Drug cost: $14,734 (USD; Tot_Drug_Cst)2016 Drug cost: $18,123 (USD; Tot_Drug_Cst)2017 Drug cost: $20,398 (USD; Tot_Drug_Cst)2018 Drug cost: $15,153 (USD; Tot_Drug_Cst)2019 Drug cost: $12,361 (USD; Tot_Drug_Cst)2020 Drug cost: $12,121 (USD; Tot_Drug_Cst)2021 Drug cost: $21,692 (USD; Tot_Drug_Cst)2022 Drug cost: $10,921 (USD; Tot_Drug_Cst)2023 Drug cost: $7,152 (USD; Tot_Drug_Cst)2024 Drug cost: $8,809 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153573$14,734
20164198$18,123
201741108$20,398
20182870$15,153
20193880$12,361
20203366$12,121
202142106$21,692
20224276$10,921
202352114$7,152
20244781$8,809

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
45385Removal of polyps or growths of large bowel using an endoscope with mechanical snare1515$373
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1624$60
G0500Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito2626$49
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more1416$39
99153Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes1313$10

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MesalamineMesalamine11480$6,743
Neomycin SulfateNeomycin Sulfate1216$74
MetronidazoleMetronidazole1325$26

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Asim Farid, M.D.?

Tedicare shows public-source Medicare data for Asim Farid, M.D. (NPI 1194785584), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Asim Farid, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Asim Farid, M.D.?

Asim Farid, M.D. is linked to ROCHESTER COLON AND RECTAL SURGEONS, PC (billing NPI 1396702411) in the available physician profile data.

Does Asim Farid, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.